Analysis of T-cell receptor β of the T-cell clones reactive to the human PDC-E2 163-176 peptide in the context of HLA-DR53 in patients with primary biliary cirrhosis

Hepatology

Volumn 26, Issue 3, 1997, Pages 728-733

  Ichiki, Yasunori ^a   Shimoda, Shinji ^a   Hara, Hideo ^b   Shigematsu, Hirohisa ^a   Nakamura, Minoru ^a   Hayashida, Kazuhiro ^a   Ishibashi, Hiromi ^a   Niho, Yoshiyuki ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA DR4 ANTIGEN; HLA DR5 ANTIGEN; PEPTIDE PDC E2 163 176; PYRUVATE DEHYDROGENASE; RECEPTOR SUBTYPE; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; BILIARY CIRRHOSIS; CELL CLONE; CLINICAL ARTICLE; CONTROLLED STUDY; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; LIGAND BINDING; PEPTIDE ANALYSIS; PRIORITY JOURNAL; RECEPTOR BINDING; T LYMPHOCYTE RECEPTOR GENE;

EID: 0030823747     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510260326     Document Type: Article

References (41)

1. Kaplan MM. Primary biliary cirrhosis. N Engl J Med 1987;316:521-528.
2. Nakanuma Y, Ohta G. Histometric and serial section observations of the intrahepatic bile ducts in primary biliary cirrhosis. Gastroenterology 1979;76:1326-1332.
3. Ballardini G, Mirakian R, Bianchi FB, Pisi E, Doniach D, Bottazzo GF. Aberrant expression of HLA-DR antigens on bile duct epithelium in primary biliary cirrhosis: relevance to pathogenesis. Lancet 1984;2: 1009-1013.
4. Adams DH, Hubscher SG, Shaw J, Johnson GD, Babbs C, Rothlein R, Neuberger JM. Increased expression of intercellular adhesion molecule 1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis. HEPATOLOGY 1991;14:426-431.
5. Van de Water J, Ansari AA, Surh CD, Coppel R, Roche T, Bonkovsky H, Kaplan M, et al. Evidence for the targeting by 2-oxo-dehydrogenase enzymes in the T cell response of primary biliary cirrhosis. J Immunol 1991;146:89-94.
6. Joplin R, Lindsay JG, Hubscher SG, Johnson GD, Shaw JC, Strain AJ, Neuberger JM. Distribution of dihydrolipoamide acetyltransferase (E2) in the liver and portal lymph nodes of patients with primary biliary cirrhosis: an immunohistochemical study. HEPATOLOGY 1991;14:442-447.
7. Van de Water J, Gershwin ME, Leung P, Ansari A, Coppel RL. The autoepitope of the 74-kD mitochondrial autoantigen of primary biliary cirrhosis corresponds to the functional site of dihydrolipoamide acetyltransferase. J Exp Med 1988;167:1791-1799.
8. Fussey SPM, Guest JR, James OFW, Bassendine MF, Yeaman SJ. Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis. Proc Natl Acad Sci U S A 1988:8654-8658.
9. Matsui M, Nakamura M, Ishibashi H, Koike K, Kudo J, Niho Y. Human monoclonal antibodies from a patient with primary biliary cirrhosis that recognize two distinct autoepitopes in the E2 component of the pyruvate dehydrogenase complex. HEPATOLOGY 1993;18:1069-1077.
10. Nakamura M, Ishibashi H, Matsui M, Shimoda S, Hayashida K, Koike K, Niho Y. Peripheral B lymphocyte repertoire to mitochondrial antigen in primary biliary cirrhosis. Positive correlation between the disease activity and the frequency of circulating B lymphocytes specific for pyruvate dehydrogenase complex. Autoimmunity 1995;21:253-262.
11. Fukushima N, Nakamura M, Matsui M, Ikematsu H, Koike K, Ishibashi H, Hayashida K, et al. Establishment and structural analysis of human mAb to the E2 component of the 2-oxoglutarate dehydrogenase complex generated from a patient with primary biliary cirrhosis. Int Immunol 1955;7:1047-1055.
12. Van de Water J, Ansari A, Prindiville T, Coppel RL, Ricalton N, Kotzin BL, Liu S, et al. Heterogeneity of autoreactive T cell clones specific for the E2 component of the pyruvate dehydrogenase complex in primary biliary cirrhosis. J Exp Med 1995;181:723-733.
13. Jones DEJ, Palmer JM, James OFW, Yeaman SJ, Bassendine MF, Diamond AG. T-cell responses to the components of pyruvate dehydrogenase complex in primary biliary cirrhosis. HEPATOLOGY 1995;21:995-1002.
14. Löhr H, Fleischer B, Gerken G, Yeaman SJ, Meyer zum Büschenfelde K-H, Manns M. Autoreactive liver-infiltrating T cells in primary biliary cirrhosis recognize inner mitochondrial epitopes and the pyruvate dehydrogenase complex. J Hepatol 1993;18:322-327.
15. Shimoda S, Nakamura M, Ishibashi H, Hayashida K, Niho Y. HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases. J Exp Med 1995;181:1835-1845.
16. Howell MD, Winters ST, Olee T, Powell HC, Carlo DJ, Brostoff SW. Vaccination against experimental allergic encephalomyelitis with T-cell receptor peptides. Science 1989;246:668-670.
17. Vandenbark AA, Hashim G, Offner H. Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature 1989;341:541-544.
18. Moebius U, Manns M, Hess G, Kober G, Meyer zum Büschenfelde K-H, Meuer SC. T cell receptor gene rearrangements of T lymphocytes infiltrating the liver in chronic active hepatitis B and primary biliary cirrhosis (PBC): oligoclonality of PBC-derived T cell clones. Eur J Immunol 1990;20:889-896.
19. Tsai SL, Lai MY, Chen DS. Analysis of rearranged T cell receptor (TCR) Vβ transcripts in livers of primary biliary cirrhosis: preferential Vβ usage suggests antigen-driven selection. Clin Exp Immunol 1996;103: 99-104.
20. Ohmoto M, Yamamoto K, Nagano T, Matsumoto S, Kobashi H, Okamoto R, Tsuji T. Accumulation of multiple T-cell clonotypes in the liver of primary biliary cirrhosis. HEPATOLOGY 1997;25:33-37.
21. Ohta Y. Report of the research subgroup of autoimmune hepatitis/primary biliary cirrhosis. Gastroenterol Jpn 1993;28(Suppl 4):128-133.
22. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
23. Wucherpfennig KW, Ota K, Endo N, Seidman JG, Rosenzweig A, Weiner HL, Hafler DA. Shared human T cell receptor Vβ usage to immunodominant regions of myelin basic protein. Science 1990;248: 1016-1019.
24. Hara H, Morita M, Iwaki T, Hatae T, Itoyama Y, Kitamoto T, Akizuki S, et al. Detection of human T lymphotrophic virus type I (HTLV- I) proviral DNA and analysis of T cell receptor Vβ CDR3 sequences in spinal cord lesions of HTLV- I -associated myelopathy/tropical spastic paraparesis. J Exp Med 1994;180:831-839.
25. Zhang J, Markovic-Plese S, Lacet B, Raus J, Weiner HL, Hafler DA. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med 1994;179: 973-984.
26. Sommer N, Harcourt GC, Willcox N, Beeson D, Newsom-Davis J. Acetylcholine receptor-reactive T lymphocytes from healthy subjects and myasthenia gravis patients. Neurology 1991;41:1270-1276.
27. Sun J-B, Olsson T, Wang W-Z, Xiao B-G, Kostulas V, Fredrikson S, Ekre H-P, et al. Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls. Eur J Immunol 1991; 21:1461-1468.
28. Tandon N, Freeman MA, Weetman AP. T cell responses to synthetic TSH receptor peptides in Graves' disease. Clin Exp Immunol 1992;89: 468-473.
29. Sloan-Lancaster J, Evavold BD, Allen PM. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature 1993;363:156-159.
30. Ohashi PS, Oehen S, Buerki K, Pircher H, Ohashi CT, Odermatt B, Malissen B, et al. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 1991;65:305-317.
31. Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994;265:1237-1240.
32. Vandevyver C, Mertens N, Van den Elsen P, Medaer R, Raus J, Zhang J. Clonal expansion of myelin basic protein-reactive T cells in patients with multiple sclerosis: restricted T cell receptor V gene rearrangements and CDR3 sequence. Eur J Immunol 1995;25:958-968.
33. Oksenberg JR, Panzara MA, Begovich AB, Mitchell D, Erlich HA, Murray RS, Shimonkevitz R, et al. Selection for T-cell receptor-Vβ -Dβ -Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature 1933;362:68-70.
34. Hafler DA, Saadeh MG, Kuchroo VK, Milford E, Steinman L. TCR usage in human and experimental demyelinating disease. Immunol Today 1996;17:152-159.
35. Ben-Nun A, Liblau RS, Cohen L, Lehmann D, Tournier-Lasserve E, Rosenzweig A, Jingwu Z, et al. Restricted T-cell receptor Vβ gene usage by myelin basic protein-specific T-cell clones in multiple sclerosis: predominant genes vary in individuals. Proc Natl Acad Sci U S A 1991; 88:2466-2470.
36. Wucherpfennig KW, Zhang J, Witek C, Matsui M, Modabber Y, Ota K, Hafler DA. Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide. J Immunol 1994; 152:5581-5592.
37. + T cell repertoire recognizing one TCR ligand. Immunol Lett, 1996;51:191-194.
38. Davis MM, Bjorkman PJ. T-cell antigen receptor genes and T-cell recognition. Nature 1988;334:395-402.
39. Chothia C, Boswell DR, Lesk AM. The outline structure of the T-cell αβ receptor. EMBO J 1988;7:3745-3755.
40. Jorgensen JL, Esser U, de St. Groth BF, Reay PA, Davis MM. Mapping T-cell receptor-peptide contacts by variant peptide immunization of single-chain transgenics. Nature 1992;355:224-230.
41. Garcia KC, Degano M, Stanfield RL, Brunmark A, Jackson MR, Peterson PA, Teyton L, et al. An αβ T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex. Science 1996;274:209-219.